Todd Rice

Critical care doc / physician scientist. Assoc Editor for Critical Care section of CHEST, Past-President ASPEN; ICU Ed and Todd-Caster

[Todd Rice @toddrice_ICU]

Thirsty for more knowledge and data? In episode 104 of the podcast, we discuss the VASSPR trial - lower vs higher norepinephrine vasopressor threshold for starting vasopressin. Hot question being asked by lots of clinicians and now we have some data.

https://t.co/2yXVPvfcoN

[Hayley Gershengorn @HBGMD]

🎯 How can we best ensure we’re in the trachea during ETT placement? 🫁

Robinson & colleagues outline the protocol for their “WAVE”trial — waveform 🌊 vs color 🟪🟨 capnography:

https://t.co/nyiBwXVJk7

#OpenAccess in #journal_CHESTCritCare

[Todd Rice @toddrice_ICU]

The ICU Ed and Todd-cast LIVE at @accpchest. We review GLP-1 use & septic shock & using sigh breaths to measure recruitability in mech vent pts. All in front of a live audience at CHEST @accpchest meeting in Phoenix. Lots of fun with this live learning.

https://t.co/IBAqVKzlQC

[Todd Rice @toddrice_ICU]

Really important work and very sobering results. But if you want to be an optimist - lots of opportunity to improve the outcomes of our patients. @WSherrillACNP and @whitney_gannon

[Hayley Gershengorn @HBGMD]

❓ Do you care for #ECMO patients? Do you wonder about their 1-year 🧠 & 💪 outcomes?

@WSherrillACNP & colleagues compare outcomes to iMV patients:

https://t.co/Swj9kx8fuy

#OpenAccess as always in #journal_CHESTCritCare!

[Todd Rice @toddrice_ICU]

In honor of our attendance/participation in the ELSO conference last week, we tackle 2 studies about ECMO - RATE & CESAR. RATE is an RCT of different anticoagulation strategies in pts on ECMO and CESAR is an oldie but goodie about ECMO for resp failure.

https://t.co/rRVpy4KWQq

[Todd Rice @toddrice_ICU]

During current heatdome, we talk about cooling (ok, technically targeted temp mgmt). ICECAP investigates duration of hypothermia in OHCA. We briefly discuss TTM2 & normothermia, too. Unfortunately, OHCA isn't rare. We need to find ways to improve outcomes.
https://t.co/9IA6tKA5lg

[Todd Rice @toddrice_ICU]

100th episode of @IcuCast. Wow!!! I can't actually believe it. I thought this was gonna be a "1 and done" adventure, but YOU, the listeners have said otherwise. In 100th episode we cover olanzapine vs. dex & reminisce about what has been & what's to come.
https://t.co/3WY65ts9Xn

[Todd Rice @toddrice_ICU]

Cycling & Protein - a love made in heaven? In episode #99 of the ICU Ed & Todd-cast (right? almost 100 episodes?), we discuss NEXIS trial & tackle some listener mail.

https://t.co/DwBM23pyAu

Stay tuned for something a bit different and special in 2 weeks for episode #100.

[Todd Rice @toddrice_ICU]

Endotoxin hemoadsorption and Mesopotamia. In Episode 98 we "babble on" (yes, pun intended) about the recently published Tigris trial and put it in context with EUPHRATES trial (JAMA 2018). Are these endotoxin filters ready for widespread clinical use?

https://t.co/1tj2hxnPgB

[Todd Rice @toddrice_ICU]

Episode 97: 2 more studies presented at #CCR26 (@CritCareReviews) - this time we discuss mucolytics in vented patients with difficult secretions (MARCH trial) and Tele-Rehab. We end with some mail about tasting bicarb (spoiler alert - sounds unpalatable).
https://t.co/gZb6Cbnbtm

[Todd Rice @toddrice_ICU]

Episode 96: More #CCR26 @CritCareReviews articles. This episode we discuss ARISE-FLUIDS and put it in the context of CLOVERS and CLASSIC and high dose vitamin C in burns (VICTORY). Plus Eddie hits me with some mail.

https://t.co/YDnLxcXQDj

[Todd Rice @toddrice_ICU]

Episode 95 - bicarb, bicarb, bicarb. We talk about 2 new studies of bicarbonate presented at #CCR2026 @CritCareReviews. How should we think about these trials and the use of bicarbonate in our clinical practice?

https://t.co/pYAq414K7L

[Critical Care Reviews @CritCareReviews]

Looking forward to listening to this!

[Todd Rice @toddrice_ICU]

Episode 94 - we talk about studies presented @ CCR26 @CritCareReviews in Belfast last week - specifically the unpublished studies - FISSH, REMAP-CAP Oseltamivir, & SAVE-ICU. If u missed the presentations, get the results & our views of their significance.
https://t.co/O1xKGrgbZg

[Todd Rice @toddrice_ICU]

Episode 93 of @IcuCast - review of articles released at ATS. But even more exciting, we cover some current events related to medicine (i.e. sepsis and hantavirus).

[Todd Rice @toddrice_ICU]

New episode of the ICU Ed and Todd-cast @IcuCast released today, examining the R2D2-ICU trial - use of soft wrist restraints & whether decreased use can increase time alive & free of coma & delirium. Interesting study & important topic for critical care.
https://t.co/6CLyLrsddZ

[Todd Rice @toddrice_ICU]

How best to treat a critically ill pt w/ agitated delirium who's not mech ventilated. We are seeing more of these pts in our practice. They can be difficult to treat. In this episode, we discuss the 4D trial & some evidence on Rx strategies for these pts.

https://t.co/8YcNLzMhlJ

[Todd Rice @toddrice_ICU]

Another podcast, and more guidelines. This time we tackle a beast - the Surviving Sepsis Campaign Guidelines. Lots to digest - but we try to boil it down to changes in this most recent version of the guidelines -hopefully distilled into a nice easy listen.
https://t.co/saEHKrSTTq

[Todd Rice @toddrice_ICU]

New ICU Ed & Todd-Cast @IcuCast episode - on important topic - the HI-PEITHO RCT of catheter directed lysis vs anticoag in pts w "intermediate" risk PE (C2 to C3R in new class scheme) https://t.co/zYPVpo0iBX. Nuanced findings result in great discussion. https://t.co/EPEEipV2qA

[Todd Rice @toddrice_ICU]

Another new episode of @IcuCast. Talking about albumin in septic shock - should we use it, if so, how and when? Or is just an expensive alternative with no real benefit. Listen in to both learn and laugh.

https://t.co/V2nGLB95xT